T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
1701
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.17M | ﹤0.01% |
15,986
-626
| -4% | -$78.3K |
|
|
CIM
1702
Chimera Investment
CIM
$993M
| $2.17M | ﹤0.01% |
48,000
-5,735
| -11% | -$239K |
|
1703
Bread Financial
BFH
$4.51B
| $2.17M | ﹤0.01% |
26,056
+512
| +2% | +$46.3K |
|
1704
Avnet
AVT
$7.87B
| $2.15M | ﹤0.01% |
53,660
-2,884
| -5% | -$124K |
|
1705
Advanced Drainage Systems
WMS
$11.3B
| $2.15M | ﹤0.01% |
18,451
-1,142
| -6% | -$127K |
|
1706
Credit Acceptance
CACC
$6.05B
| $2.14M | ﹤0.01% |
4,720
-356
| -7% | -$146K |
|
1707
Cabot Corp
CBT
$4.45B
| $2.13M | ﹤0.01% |
37,339
-1,255
| -3% | -$73.7K |
|
1708
SiriusXM
SIRI
$9.43B
| $2.12M | ﹤0.01% |
32,483
-14,665
| -31% | -$920K |
|
1709
Pediatrix Medical
MD
$2.15B
| $2.12M | ﹤0.01% |
70,278
-4,960
| -7% | -$146K |
|
|
EPZM
1710
DELISTED
Epizyme, Inc
EPZM
| $2.11M | ﹤0.01% |
254,366
-685,865
| -73% | -$5.78M |
|
1711
DigitalBridge
DBRG
$2.95B
| $2.11M | ﹤0.01% |
66,697
+3,064
| +5% | +$87.6K |
|
1712
Bank of Hawaii
BOH
$3.13B
| $2.1M | ﹤0.01% |
24,982
-4,031
| -14% | -$361K |
|
|
BPFH
1713
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $2.1M | ﹤0.01% |
142,044
-9,708
| -6% | -$142K |
|
1714
NIO
NIO
$11.3B
| $2.09M | ﹤0.01% |
39,300
| – | – |
|
|
XHR
1715
Xenia Hotels & Resorts
XHR
$1.73B
| $2.09M | ﹤0.01% |
111,599
-21,530
| -16% | -$415K |
|
1716
Quince Therapeutics
QNCX
$31.8M
| $2.09M | ﹤0.01% |
+197
| New | +$1.65M |
|
1717
Glaukos
GKOS
$11.2B
| $2.08M | ﹤0.01% |
24,469
+1,043
| +4% | +$85.6K |
|
1718
Progyny
PGNY
$1.99B
| $2.07M | ﹤0.01% |
35,070
+20,955
| +148% | +$1.18M |
|
1719
Tronox
TROX
$958M
| $2.06M | ﹤0.01% |
91,899
+7,938
| +9% | +$174K |
|
1720
Stock Yards Bancorp
SYBT
$2.64B
| $2.05M | ﹤0.01% |
40,346
-2,119
| -5% | -$109K |
|
1721
Olin
OLN
$2.17B
| $2.05M | ﹤0.01% |
44,349
-793
| -2% | -$35.7K |
|
|
ARNA
1722
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.04M | ﹤0.01% |
29,963
-2,227
| -7% | -$145K |
|
1723
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $2.04M | ﹤0.01% |
4,765
-10
| -0.2% | -$4.17K |
|
|
SAIL
1724
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $2.03M | ﹤0.01% |
39,758
+1,745
| +5% | +$83.8K |
|
1725
BOK Financial
BOKF
$8.85B
| $2.02M | ﹤0.01% |
23,299
+1,467
| +7% | +$131K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.